Burning Rock Biotech (FRA:6BU0) Valuation Rank


FRA:6BU0 Burning Rock Biotech Ltd FRA:6BU0
56 GF Score
Price €9.10
GF Value €6.36
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Burning Rock Biotech Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Burning Rock Biotech Valuation Rank Related Terms

FRA:6BU0
56GF Score
Burning Rock Biotech Ltd FRA:6BU0
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Burning Rock Biotech (FRA:6BU0) Overvalued in 2026?

Based on GuruFocus' analysis, Burning Rock Biotech stock appears to be overvalued. The current stock price of €9.10 is trading 43.1% above its estimated GF Value™ of €6.36. GuruFocus considers Burning Rock Biotech to be Significantly Overvalued.

Key valuation signals for FRA:6BU0:

  • Valuation Rank:
  • GF Value™: €6.36 vs. price of €9.10 (43.1% above fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the FRA:6BU0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Burning Rock Biotech Business Description

Other Exchanges BNR:USA
Address No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
56GF Score

Get the complete analysis for FRA:6BU0

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.10
Price
€6.36
GF Value